CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice.
van Wanrooij EJ, de Jager SC, van Es T, de Vos P, Birch HL, Owen DA, Watson RJ, Biessen EA, Chapman GA, van Berkel TJ, Kuiper J.
van Wanrooij EJ, et al. Among authors: de vos p, de jager sc.
Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):251-7. doi: 10.1161/ATVBAHA.107.147827. Epub 2007 Nov 29.
Arterioscler Thromb Vasc Biol. 2008.
PMID: 18048768